Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
Life Sciences Funds Generate Healthy November Gains
Stephen Taub
December 12, 2023
Premium
Haidar Is Down 50 Percent
Stephen Taub
December 11, 2023
Premium
How Third Point Fared After Increasing Bets on Stocks
Stephen Taub
December 7, 2023
Premium
Prominent Hedge Funds Stand to Benefit From Biopharma’s Change of Plans
Stephen Taub
December 6, 2023
Premium
Biopharma Bonanza
Stephen Taub
December 5, 2023
Premium
Greenlight Suffers a Setback in November
Stephen Taub
December 4, 2023
Premium
Soleus Goes Activist
Stephen Taub
November 30, 2023
Premium
Hedge Funds Eye Next Biopharma IPO
Stephen Taub
November 29, 2023
Premium
Deerfield Launches New VC Fund
Stephen Taub
November 28, 2023
Premium
Narrow Trade
Stephen Taub
November 27, 2023
Premium
Hedgies Shop for Instacart
Stephen Taub
November 22, 2023
Premium
Stan Druckenmiller Condolidates His Stock Holdings
Stephen Taub
November 21, 2023
Premium
Third Point’s Credit Bet
Stephen Taub
November 20, 2023
Premium
A Look Into Tiger Descendants’ Activity in the Third-Quarter
Stephen Taub
November 16, 2023
Premium
TCI, Whale Rock and Other Hedge Funds Made Major Moves in the Third-Quarter
Stephen Taub
November 15, 2023
Premium
Casdin Leads Ailing Life Sciences Fund Losses
November 14, 2023
Premium
Bridgewater Launches Two Funds
Stephen Taub
November 13, 2023
Premium
Greenlight Sharply Cuts Its Market Bet
Stephen Taub
November 9, 2023
More Articles